跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAPLE CHILDREN’S LORATADINE loratadine 5mg/5mL oral syrup liquid bottle - TGA Drug Approval Details
Approvals
/
TGA
/
MAPLE CHILDREN’S LORATADINE loratadine 5mg/5mL oral syrup liquid bottle
Approved
STANDARD
MAPLE CHILDREN’S LORATADINE loratadine 5mg/5mL oral syrup liquid bottle
Maple Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9c4badf44ab14bbc
Company
Maple Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
9c4badf44ab14bbc
Product Name
MAPLE CHILDREN’S LORATADINE loratadine 5mg/5mL oral syrup liquid bottle
Artg Id
454494
Artg Name
MAPLE CHILDREN’S LORATADINE loratadine 5mg/5mL oral syrup liquid bottle
Sponsor
Maple Healthcare Pty Ltd
Company Detail Path
/organization/maple-healthcare-pty-ltd
Artg Date
2024-07-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9c4badf44ab14bbc
Type
Standard
Back to TGA Approvals